• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 康复后运动员的心肌炎:系统评价和荟萃分析。

Myocarditis in Athletes Recovering from COVID-19: A Systematic Review and Meta-Analysis.

机构信息

Sports Medicine Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Catholic University, 00168 Rome, Italy.

Department of Geriatrics, Neurosciences, Orthopaedics and Head and Neck, Università Cattolica del Sacro Cuore-Fondazione Policlinico 'Agostino Gemelli' IRCCS, 00168 Rome, Italy.

出版信息

Int J Environ Res Public Health. 2022 Apr 2;19(7):4279. doi: 10.3390/ijerph19074279.

DOI:10.3390/ijerph19074279
PMID:35409960
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8998516/
Abstract

BACKGROUND

To assess the event rates of myocarditis detected by Cardiac Magnetic Resonance (CMR) in athletes who recovered from COVID-19.

METHODS

A systematic literature search was performed to identify studies reporting abnormal CMR findings in athletes who recovered from COVID-19. Secondary analyses were performed considering increased serum high sensitivity troponin (hs-Tn) levels and electrocardiographic (ECG) and echocardiographic (ECHO) abnormalities.

RESULTS

In total, 7988 athletes from 15 studies were included in the analysis. The pooled event rate of myocarditis was 1% (CI 1-2%), reaching 4% in the sub-group analysis. In addition, heterogeneity was observed (I2 43.8%). The pooled event rates of elevated serum hs-Tn levels, abnormal ECG and ECHO findings were 2% (CI 1-5%), 3% (CI 1-10%) and 2% (CI 1-6%), respectively. ECG, ECHO and serum hs-Tn level abnormalities did not show any correlation with myocarditis.

CONCLUSIONS

The prevalence of COVID-19-related myocarditis in the athletic population ranges from 1 to 4%. Even if the event rate is quite low, current screening protocols are helpful tools for a safe return to play to properly address CMR studies.

TRIAL REGISTRATION

the study protocol was registered in the PROSPERO database (registration number: CRD42022300819).

摘要

背景

评估 COVID-19 康复运动员中心脏磁共振(CMR)检测到的心肌炎发生率。

方法

进行了系统的文献检索,以确定报告 COVID-19 康复运动员异常 CMR 结果的研究。进行了二次分析,考虑了血清高敏肌钙蛋白(hs-Tn)水平升高以及心电图(ECG)和超声心动图(ECHO)异常。

结果

共纳入来自 15 项研究的 7988 名运动员进行分析。心肌炎的总发生率为 1%(95%CI 1-2%),亚组分析中为 4%。此外,观察到异质性(I2 43.8%)。血清 hs-Tn 水平升高、ECG 和 ECHO 异常的总发生率分别为 2%(95%CI 1-5%)、3%(95%CI 1-10%)和 2%(95%CI 1-6%)。ECG、ECHO 和血清 hs-Tn 水平异常与心肌炎之间无相关性。

结论

在运动员人群中,COVID-19 相关心肌炎的患病率为 1%至 4%。即使发生率相当低,但目前的筛查方案是有助于安全重返运动的有用工具,可以正确进行 CMR 研究。

注册

该研究方案已在 PROSPERO 数据库中注册(注册号:CRD42022300819)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e49c/8998516/d68e8c9edd76/ijerph-19-04279-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e49c/8998516/af2a84a2c72e/ijerph-19-04279-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e49c/8998516/d68e8c9edd76/ijerph-19-04279-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e49c/8998516/af2a84a2c72e/ijerph-19-04279-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e49c/8998516/d68e8c9edd76/ijerph-19-04279-g002.jpg

相似文献

1
Myocarditis in Athletes Recovering from COVID-19: A Systematic Review and Meta-Analysis.COVID-19 康复后运动员的心肌炎:系统评价和荟萃分析。
Int J Environ Res Public Health. 2022 Apr 2;19(7):4279. doi: 10.3390/ijerph19074279.
2
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
3
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
4
Thoracic imaging tests for the diagnosis of COVID-19.用于 COVID-19 诊断的胸部影像学检查。
Cochrane Database Syst Rev. 2022 May 16;5(5):CD013639. doi: 10.1002/14651858.CD013639.pub5.
5
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
6
Cardiac MRI Findings in COVID-19 Vaccine-Related Myocarditis: A Pooled Analysis of 468 Patients.COVID-19 疫苗相关心肌炎的心脏 MRI 表现:468 例患者的汇总分析。
J Magn Reson Imaging. 2022 Oct;56(4):971-982. doi: 10.1002/jmri.28268. Epub 2022 May 25.
7
SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.用于治疗 COVID-19 的 SARS-CoV-2 中和单克隆抗体。
Cochrane Database Syst Rev. 2021 Sep 2;9(9):CD013825. doi: 10.1002/14651858.CD013825.pub2.
8
Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.首次就诊时磁共振灌注成像用于鉴别低级别与高级别胶质瘤
Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD011551. doi: 10.1002/14651858.CD011551.pub2.
9
Cardiac complications following mRNA COVID-19 vaccines: A systematic review of case reports and case series.mRNA COVID-19 疫苗接种后的心脏并发症:病例报告和病例系列的系统评价。
Rev Med Virol. 2022 Jul;32(4):e2318. doi: 10.1002/rmv.2318. Epub 2021 Dec 17.
10
Return to sport following navicular stress fracture: a systematic review and meta-analysis of three hundred and fifteen fractures.足舟骨应力性骨折后重返运动:315 例骨折的系统评价和荟萃分析。
Int Orthop. 2021 Oct;45(10):2699-2710. doi: 10.1007/s00264-021-05147-6. Epub 2021 Aug 20.

引用本文的文献

1
Echocardiography in the cardiac assessment of young athletes: a 2025 guideline from the British Society of Echocardiography (endorsed by Cardiac Risk in the Young).超声心动图在年轻运动员心脏评估中的应用:英国超声心动图学会2025年指南(由青年心脏风险组织认可)
Echo Res Pract. 2025 Mar 14;12(1):7. doi: 10.1186/s44156-025-00069-0.
2
Systematic review: characteristics of myocarditis followed by fixed drug eruption and dry eye syndrome in patients who have been vaccinated with monkeypox in children and adults.系统评价:儿童和成人接种猴痘疫苗后发生固定型药疹和干眼症的心肌炎患者的特征
Front Cardiovasc Med. 2025 Jan 29;11:1505298. doi: 10.3389/fcvm.2024.1505298. eCollection 2024.
3

本文引用的文献

1
Prevalence and Clinical Implications of COVID-19 Myocarditis.COVID-19 心肌炎的流行情况及其临床意义。
Card Electrophysiol Clin. 2022 Mar;14(1):53-62. doi: 10.1016/j.ccep.2021.11.001. Epub 2021 Nov 9.
2
Cardiovascular involvement among collegiate athletes following COVID-19 infection.新冠病毒感染后大学生运动员的心血管受累情况。
J Clin Transl Res. 2022 Jan 3;8(1):1-5. eCollection 2022 Feb 25.
3
SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study.严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)疫苗接种与心肌炎或心肌心包炎:基于人群的队列研究
Mpox in sports: A comprehensive framework for anticipatory planning and risk mitigation in football based on lessons from COVID-19.
体育领域的猴痘:基于新冠疫情经验教训的足球前瞻性规划与风险缓解综合框架
Biol Sport. 2024 Oct;41(4):317-335. doi: 10.5114/biolsport.2024.144014. Epub 2024 Oct 10.
4
Return-to-Play Post-Myocarditis for Athletes: To Play or Not to Play?运动员心肌炎后重返赛场:参赛与否?
Diagnostics (Basel). 2024 Oct 7;14(19):2236. doi: 10.3390/diagnostics14192236.
5
Myocarditis - A silent killer in athletes: Comparative analysis on the evidence before and after COVID-19 pandemic.心肌炎——运动员中的隐形杀手:COVID-19大流行前后证据的比较分析
Sports Med Health Sci. 2024 Mar 16;6(3):232-239. doi: 10.1016/j.smhs.2024.03.003. eCollection 2024 Sep.
6
The Impact of the COVID-19 Pandemic on Elite Swimmers and Water Polo Players: Lessons for the Future.新冠疫情对精英游泳运动员和水球运动员的影响:未来的经验教训。
Epidemiologia (Basel). 2024 Jun 18;5(2):289-308. doi: 10.3390/epidemiologia5020020.
7
Prevalence of Abnormal Cardiovascular Magnetic Resonance Findings in Athletes Recovered from COVID-19 Infection: A Systematic Review and Meta-Analysis.新冠病毒感染康复运动员心血管磁共振异常表现的患病率:一项系统评价与荟萃分析
J Clin Med. 2024 Jun 3;13(11):3290. doi: 10.3390/jcm13113290.
8
Return to play of young and adult professional athletes after COVID-19: A scoping review.新型冠状病毒肺炎后青少年及成年职业运动员的重返赛场:一项范围综述
J Exerc Sci Fit. 2024 Jul;22(3):208-220. doi: 10.1016/j.jesf.2024.03.005. Epub 2024 Mar 18.
9
Paucisymptomatic post COVID-19 myocarditis in a young athlete during return to play workflow: possible usefulness of global longitudinal strain analysis.COVID-19 后轻症心肌炎在年轻运动员重返赛场流程中的作用:整体纵向应变分析的可能价值。
BMJ Case Rep. 2024 Jan 12;17(1):e255863. doi: 10.1136/bcr-2023-255863.
10
Myocarditis in Athletes: Risk Factors and Relationship with Strenuous Exercise.运动员心肌炎:危险因素及其与剧烈运动的关系
Sports Med. 2024 Mar;54(3):607-621. doi: 10.1007/s40279-023-01969-z. Epub 2023 Dec 11.
BMJ. 2021 Dec 16;375:e068665. doi: 10.1136/bmj-2021-068665.
4
Is cardiac involvement prevalent in highly trained athletes after SARS-CoV-2 infection? A cardiac magnetic resonance study using sex-matched and age-matched controls.在感染 SARS-CoV-2 后,高度训练有素的运动员是否普遍存在心脏受累?一项使用性别匹配和年龄匹配对照的心脏磁共振研究。
Br J Sports Med. 2022 May;56(10):553-560. doi: 10.1136/bjsports-2021-104576. Epub 2021 Nov 30.
5
SARS-CoV-2 infection and return to play in junior competitive athletes: is systematic cardiac screening needed?严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染与青少年竞技运动员恢复参赛:是否需要进行系统性心脏筛查?
Br J Sports Med. 2022 Mar;56(5):264-270. doi: 10.1136/bjsports-2021-104764. Epub 2021 Nov 29.
6
Cardiac Screening in a Young Adult Male Leading to Discovery of Post-COVID Myocarditis with Asymptomatic Large Apical Left Ventricular Thrombus.对一名年轻成年男性进行心脏筛查,发现其患有新冠后心肌炎并伴有无症状的巨大心尖部左心室血栓。
CASE (Phila). 2021 Aug 14;5(5):309-312. doi: 10.1016/j.case.2021.07.008. eCollection 2021 Oct.
7
Cardiac abnormalities in athletes after SARS-CoV-2 infection: a systematic review.SARS-CoV-2感染后运动员的心脏异常:一项系统综述
BMJ Open Sport Exerc Med. 2021 Oct 12;7(4):e001164. doi: 10.1136/bmjsem-2021-001164. eCollection 2021.
8
Myocarditis after Covid-19 Vaccination in a Large Health Care Organization.大型医疗机构中接种新冠疫苗后的心肌炎。
N Engl J Med. 2021 Dec 2;385(23):2132-2139. doi: 10.1056/NEJMoa2110737. Epub 2021 Oct 6.
9
Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel.以色列接种 BNT162b2 mRNA 疫苗后出现心肌炎。
N Engl J Med. 2021 Dec 2;385(23):2140-2149. doi: 10.1056/NEJMoa2109730. Epub 2021 Oct 6.
10
Myocardial Pathology in COVID-19-Associated Cardiac Injury: A Systematic Review.新型冠状病毒肺炎相关心脏损伤的心肌病理学:一项系统评价
Diagnostics (Basel). 2021 Sep 8;11(9):1647. doi: 10.3390/diagnostics11091647.